INC Research/inventive Health, biopharmaceutical solutions organization combining CRO and CCO (Contract Commercial Organization), announced it was awarded the 2017 Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category during the SCRS Annual Global Site Solutions Summit held earlier this month.
The award recognizes the CRO that best exemplifies leadership, professionalism, integrity, passion, and dedication to advancing clinical research through strong site partnerships. Finalists were selected by nominations from SCRS members-nearly 9,000 research sites in 45 countries. Selection criteria included availability of qualified staff to support sites, willingness to collaborate, protocol design and execution, financial consideration and partnering with sites for future work. CROs that ranked in the 75th percentile or above in the initial round of voting were then moved to a final ballot. All sites, regardless of SCRS membership, were able to select a winner for announcement at the Summit.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.